Lixte Biotechnology Stock (NASDAQ: LIXT) stock price, news, charts, stock research, profile.
Open | $3.260 |
Close | $3.220 |
Volume / Avg. | 14.871K / 555.455K |
Day Range | 3.105 - 3.400 |
52 Wk Range | 1.580 - 9.500 |
Market Cap | $7.310M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 0.76% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lixte Biotechnology (NASDAQ: LIXT) through any online brokerage.
Other companies in Lixte Biotechnology’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX) and NuCana (NASDAQ:NCNA).
There is no analysis for Lixte Biotechnology.
The stock price for Lixte Biotechnology (NASDAQ: LIXT) is $3.25 last updated April 24, 2024 at 9:07 AM EDT.
There are no upcoming dividends for Lixte Biotechnology.
Lixte Biotechnology’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Lixte Biotechnology.
Lixte Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.